Get the Stockscreener App
0.0469
50.11%
-0.0471
Valeo Pharma Inc - Class A Stock (VPHIF) Forecast
The Valeo Pharma Inc - Class A (VPHIF) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $0.365, representing a +678.25% increase from the current price of $0.0469. The highest analyst price target is $0.5013, and the lowest is $0.2287.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month VPHIF Price Target
Average 0.365
(+678.25% Upside)
Long-term VPHIF price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Valeo Pharma Inc - Class A financial reports and earnings history, Valeo Pharma Inc - Class A (VPHIF) stock could reach $0.4885 by 2030, $0.4578 by 2040 and $0.5013 by 2050. See the projected annual prices until 2050 of the Valeo Pharma Inc - Class A stock below:
- Valeo Pharma Inc - Class A (VPHIF) is expected to reach an average price of $0.4947 in 2035, with a high prediction of $0.5013 and a low estimate of $0.4798. This indicates an $954.80% rise from the last recorded price of $0.0469.
- Valeo Pharma Inc - Class A (VPHIF) stock is projected to chart a bullish course in 2040, with an average price target of $0.4108, representing an $775.91% surge from its current level. The forecast ranges from a conservative $0.2287 to a sky-high $0.4578.
- Our analysts predict Valeo Pharma Inc - Class A (VPHIF) to jump 923.03% by 2045, soaring from $0.2803 to an average price of $0.4798, potentially reaching $0.4885. While $0.2803 is the low estimate, the potential upside is significant.
- Valeo Pharma Inc - Class A (VPHIF) stock is expected to climb by 2050, reaching an average of $0.2287, a $387.63% jump from its current level. However, a wide range of estimates exists, with high and low targets of $0.5013 and $0.2287, respectively, highlighting the market's uncertainty.
Valeo Pharma Inc - Class A Stock (VPHIF) Year by Year Forecast
Valeo Pharma Inc - Class A Stock (VPHIF) Price Forecast for 2025
Valeo Pharma Inc - Class A Stock (VPHIF) is expected to reach an average price of $0.365 in 2025, with a high prediction of $0.5013 and a low estimate of $0.2287. This indicates an +678.25% rise from the last recorded price of $0.0469.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| August, 2025 | $0.445 | $0.2287 | $0.5013 | +848.92% |
| September, 2025 | $0.4313 | $0.24 | $0.4427 | +819.62% |
| October, 2025 | $0.4798 | $0.2803 | $0.4885 | +923.03% |
| November, 2025 | $0.49 | $0.4798 | $0.5013 | +944.78% |
| December, 2025 | $0.4108 | $0.2287 | $0.4578 | +775.91% |
Valeo Pharma Inc - Class A Stock (VPHIF) Price Forecast for 2026
The predicted value for Valeo Pharma Inc - Class A (VPHIF) in 2026 is set at an average of $0.365. Estimates vary from a peak of $0.5013 to a trough of $0.2287, indicating an +678.25% surge from the present price of $0.0469.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $0.4555 | $0.24 | $0.4885 | +871.22% |
| February, 2026 | $0.4947 | $0.4798 | $0.5013 | +954.80% |
| March, 2026 | $0.445 | $0.2287 | $0.4936 | +848.92% |
| April, 2026 | $0.4313 | $0.24 | $0.4427 | +819.62% |
| May, 2026 | $0.4798 | $0.2803 | $0.4885 | +923.03% |
| June, 2026 | $0.49 | $0.4798 | $0.5013 | +944.78% |
| July, 2026 | $0.24 | $0.2287 | $0.4578 | +411.73% |
| August, 2026 | $0.4555 | $0.2803 | $0.4885 | +871.22% |
| September, 2026 | $0.4947 | $0.4798 | $0.5013 | +954.80% |
| October, 2026 | $0.4427 | $0.2287 | $0.4936 | +843.92% |
| November, 2026 | $0.4885 | $0.24 | $0.4885 | +941.58% |
| December, 2026 | $0.4798 | $0.2803 | $0.4798 | +923.03% |
Valeo Pharma Inc - Class A Stock (VPHIF) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Valeo Pharma Inc - Class A (VPHIF) is $0.365, with a high forecast of $0.5013 and a low forecast of $0.2287. This indicates an +678.25% increase from the last price of $0.0469.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.2287 | $0.2287 | $0.5013 | +387.63% |
| February, 2027 | $0.24 | $0.24 | $0.4578 | +411.73% |
| March, 2027 | $0.4555 | $0.2803 | $0.4885 | +871.22% |
| April, 2027 | $0.4936 | $0.4798 | $0.5013 | +952.45% |
| May, 2027 | $0.4427 | $0.2287 | $0.49 | +843.92% |
| June, 2027 | $0.4885 | $0.24 | $0.4885 | +941.58% |
| July, 2027 | $0.4798 | $0.2803 | $0.4798 | +923.03% |
| August, 2027 | $0.2287 | $0.2287 | $0.5013 | +387.63% |
| September, 2027 | $0.24 | $0.24 | $0.4578 | +411.73% |
| October, 2027 | $0.4798 | $0.2803 | $0.4885 | +923.03% |
| November, 2027 | $0.4936 | $0.4798 | $0.5013 | +952.45% |
| December, 2027 | $0.4108 | $0.2287 | $0.49 | +775.91% |
Valeo Pharma Inc - Class A Stock (VPHIF) Price Forecast for 2028
In 2028, Valeo Pharma Inc - Class A (VPHIF) is projected to reach an average price of $0.365, with a high projection of $0.5013 and a low estimate of $0.2287. This indicates an +678.25% rise from the last price of $0.0469.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.2803 | $0.24 | $0.4885 | +497.65% |
| February, 2028 | $0.4798 | $0.4555 | $0.4798 | +923.03% |
| March, 2028 | $0.445 | $0.2287 | $0.5013 | +848.92% |
| April, 2028 | $0.4313 | $0.24 | $0.4427 | +819.62% |
| May, 2028 | $0.4798 | $0.2803 | $0.4885 | +923.03% |
| June, 2028 | $0.49 | $0.4798 | $0.5013 | +944.78% |
| July, 2028 | $0.4108 | $0.2287 | $0.4578 | +775.91% |
| August, 2028 | $0.2803 | $0.24 | $0.4885 | +497.65% |
| September, 2028 | $0.4947 | $0.4555 | $0.5013 | +954.80% |
| October, 2028 | $0.445 | $0.2287 | $0.4936 | +848.92% |
| November, 2028 | $0.4313 | $0.24 | $0.4427 | +819.62% |
| December, 2028 | $0.4798 | $0.2803 | $0.4885 | +923.03% |
Valeo Pharma Inc - Class A Stock (VPHIF) Price Forecast for 2029
The 2029 price forecast for Valeo Pharma Inc - Class A Stock (VPHIF) is $0.365 on average, with a high prediction of $0.5013 and a low estimate of $0.2287. This represents an +678.25% increase from the previous price of $0.0469.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.49 | $0.4798 | $0.5013 | +944.78% |
| February, 2029 | $0.4108 | $0.2287 | $0.4578 | +775.91% |
| March, 2029 | $0.4555 | $0.24 | $0.4885 | +871.22% |
| April, 2029 | $0.4947 | $0.4798 | $0.5013 | +954.80% |
| May, 2029 | $0.445 | $0.2287 | $0.4936 | +848.92% |
| June, 2029 | $0.4885 | $0.24 | $0.4885 | +941.58% |
| July, 2029 | $0.4798 | $0.2803 | $0.4798 | +923.03% |
| August, 2029 | $0.2287 | $0.2287 | $0.5013 | +387.63% |
| September, 2029 | $0.24 | $0.24 | $0.4578 | +411.73% |
| October, 2029 | $0.4555 | $0.2803 | $0.4885 | +871.22% |
| November, 2029 | $0.4936 | $0.4798 | $0.5013 | +952.45% |
| December, 2029 | $0.4427 | $0.2287 | $0.49 | +843.92% |
Valeo Pharma Inc - Class A Stock (VPHIF) Price Forecast for 2030
Valeo Pharma Inc - Class A Stock (VPHIF) is expected to reach an average price of $0.365 in 2030, with a high forecast of $0.5013 and a low forecast of $0.2287. This signifies an +678.25% surge from the last price of $0.0469.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $0.4885 | $0.24 | $0.4885 | +941.58% |
| February, 2030 | $0.4798 | $0.2803 | $0.4798 | +923.03% |
| March, 2030 | $0.2287 | $0.2287 | $0.5013 | +387.63% |
| April, 2030 | $0.24 | $0.24 | $0.4578 | +411.73% |
| May, 2030 | $0.4798 | $0.2803 | $0.4885 | +923.03% |
| June, 2030 | $0.4936 | $0.4798 | $0.5013 | +952.45% |
| July, 2030 | $0.4427 | $0.2287 | $0.49 | +843.92% |
| August, 2030 | $0.2803 | $0.24 | $0.4885 | +497.65% |
| September, 2030 | $0.4798 | $0.4555 | $0.4798 | +923.03% |
| October, 2030 | $0.2287 | $0.2287 | $0.5013 | +387.63% |
| November, 2030 | $0.4313 | $0.24 | $0.4578 | +819.62% |
| December, 2030 | $0.4798 | $0.2803 | $0.4885 | +923.03% |
1.39%
0.34%
Cap:
|
Volume (24h):